Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Zhiwei Zhong | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Zhiwei Zhong | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Nanchang University | China

Dr. Zhiwei Zhong’s research focuses on molecular oncology, nanomedicine, and biomarker discovery in complex diseases such as pancreatic cancer, hepatocellular carcinoma, thyroid eye disease, and venous thromboembolism. His studies integrate bioinformatics, molecular biology, and nanotechnology to uncover therapeutic targets and diagnostic biomarkers. Zhong has contributed to several high-impact publications in PLOS One, Cancer Cell International, Oncology Reports, Digestive Diseases and Sciences, and SN Applied Sciences. His notable works include identifying key extracellular proteins (EGFR, CD44, and CXCL8) as potential biomarkers in thyroid eye disease, elucidating the regulatory role of lncRNA FTX in suppressing NAFLD progression to hepatocellular carcinoma via Kupffer cell polarization, and exploring nanoparticle-based drug delivery systems for targeted thrombolysis and cancer therapy. He has also investigated tumor suppressor mechanisms involving KLF9 and CHD1L in pancreatic cancer, providing insights into tumor proliferation, invasion, and survival pathways. His research contributions advance the understanding of molecular pathogenesis, precision diagnostics, and targeted nanotherapeutic strategies in human diseases.

Profile: ORCID

Featured Publications

  1. He, S., Nie, H., Yin, X., & Zhong, Z. (2025, April). Identification of key extracellular proteins as the potential biomarkers in thyroid eye disease. PLOS ONE, 20(4), e0322415. https://doi.org/10.1371/journal.pone.0322415

Oguz Ozcelik | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Oguz Ozcelik | Medicine and Health Sciences | Best Researcher Award

Kastamonu University | Turkey

Dr. Oğuz Özçelik (MD, PhD) is a distinguished Professor at Kastamonu University, Turkey, widely recognized for his pioneering work in exercise physiology, metabolism, and oxidative stress. His academic foundation in medicine and physiology has driven decades of impactful research exploring the complex relationships between aerobic fitness, respiratory regulation, and metabolic health. Through rigorous experimental design and translational insights, he has advanced understanding of how exercise modulates physiological and biochemical responses in both healthy and clinical populations. Dr. Oğuz Özçelik’s scientific contributions span more than forty peer-reviewed publications in international journals, reflecting depth, innovation, and clinical relevance. His notable works include studies on the relationship between aerobic fitness levels and isocapnic buffering periods during incremental exercise tests (Cellular and Molecular Biology, 2017, cited by 132), the effects of body mass index on maximal work production and aerobic capacity (Physiological Research, 2004, cited by 84), and the role of nesfatin-1 in glucose tolerance and depressive disorders (Physiological Research, 2016; Psychiatry Investigation, 2018). With an h-index of 13 and more than 474 citations, his scholarly influence demonstrates sustained research excellence. Dr. Oğuz Özçelik’s current investigations focus on the hormonal and metabolic adaptations to exercise and their relevance to neuroendocrine and cardiometabolic health. His leadership, academic rigor, and enduring contributions to human performance and biomedical science exemplify the highest standards of professional achievement and research integrity within the global scientific community.

Profile: Scopus | Google Scholar | ORCID

Featured Publications

  1. Algul, S., Ozcelik, O., & Yilmaz, B. (2017). Evaluation of relationship between aerobic fitness level and range of isocapnic buffering periods during incremental exercise test. Cellular and Molecular Biology, 63(3), 78–82.

  2. Ozcelik, O., Aslan, M., Ayar, A., & Kelestimur, H. (2004). Effects of body mass index on maximal work production capacity and aerobic fitness during incremental exercise. Physiological Research, 53(2), 165–170.

  3. Algul, S., Ozkan, Y., & Ozcelik, O. (2016). Serum nesfatin-1 levels in patients with different glucose tolerance levels. Physiological Research, 65(6), 979–985.

  4. Ozcelik, O., Ward, S. A., & Whipp, B. J. (1999). Effect of altered body CO₂ stores on pulmonary gas exchange dynamics during incremental exercise in humans. Experimental Physiology, 84(5), 999–1011.

  5. Algul, S., & Ozcelik, O. (2018). Evaluating the levels of nesfatin-1 and ghrelin hormones in patients with moderate and severe major depressive disorders. Psychiatry Investigation, 15(2), 214–218.

Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Mr. Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Beijing Stomatological Hospital Affiliated to Capital Medical University | China

Hanchen Zhou, a graduate student at Beijing Stomatological Hospital, Capital Medical University, is an emerging researcher specializing in Oral and Maxillofacial-Head and Neck Oncology, with a primary focus on oral squamous cell carcinoma. He has already distinguished himself by publishing four SCI-indexed research papers that contribute valuable insights into the molecular mechanisms, clinical behavior, and potential treatment strategies for this aggressive malignancy. These publications, cited internationally, reflect his growing influence in oncology research and his ability to translate clinical challenges into innovative scientific solutions. Zhou is actively engaged in funded research projects, including the Innovation Foundation and the Clinical Research Incubation Project of Beijing Stomatological Hospital, demonstrating his capacity to design and execute impactful investigations. A member of the Chinese Stomatological Association, he actively participates in academic collaboration and professional development, strengthening his role within the wider scientific community. Despite being in the early stages of his career, Zhou has already showcased a strong commitment to advancing cancer research, particularly in bridging experimental findings with clinical applications. His work not only enhances the understanding of oral squamous cell carcinoma but also paves the way for improved diagnostic and therapeutic approaches. By integrating scientific rigor with a clear vision for innovation, he exemplifies the qualities of a promising researcher poised for long-term impact.

Profile: Scopus | ResearchGate

Featured Publications

  • Yu, H., Li, B., Huang, Y., & Zhang, X. (2025). Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: A retrospective cohort analysis. Frontiers in Oncology, 15, Article 1667226. https://doi.org/10.3389/fonc.2025.1667226

  • Zhou, H., Luo, C., Xu, Q., & Wang, C. (2025). Machine learning approach to predict surgical site infection in head and neck squamous cell carcinoma patients after free flap reconstruction. Journal of Cranio-Maxillofacial Surgery. Advance online publication. https://doi.org/10.1016/j.jcms.2025.09.010

  • Cheng, A., Wei, K., Xu, Q., & Wang, C. (2025). The comparison of the prognostic value of different inflammation-related indicators in patients with oral squamous cell carcinoma. Frontiers in Genetics, 16, Article 1652603. https://doi.org/10.3389/fgene.2025.1652603

  • Li, B., Zhao, Z., Huang, Y., & Zhou, H. (2025). The application of adjuvant radiotherapy in pN1 OSCC patients without adverse pathologic features. Oral Diseases, 31(1), e15336. https://doi.org/10.1111/odi.15336

Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Mr. Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Chaoyang Hospital | China

Mr. Zhechun Wu is a resident physician in the Department of Urology at Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, who has established himself as an emerging clinician–scientist combining medical training with impactful research. He earned his Bachelor of Science degree from Capital Medical University and is currently advancing his clinical expertise through residency while contributing to translational oncology research. His work is focused on prostate cancer, with particular emphasis on identifying therapeutic targets that regulate tumor immunity, a critical area for developing next-generation treatment strategies. Mr. Zhechun Wu has published in reputable international journals, including a recent article in Investigational New Drugs that explored drug targets modulating tumor immune response, a study that has already been cited in related scholarly work, reflecting its scientific significance. His projects are supported by competitive funding from the National Natural Science Foundation of China  and the Beijing Natural Science Foundation, highlighting his ability to secure prestigious grants and deliver research with clinical and academic value. Alongside research, his clinical practice in urology, oncology, and kidney transplantation strengthens his understanding of patient-centered challenges, allowing him to align laboratory findings with real-world medical needs. This dual role as physician and researcher equips him to contribute to both advancing cancer therapeutics and improving clinical outcomes, establishing a foundation for future leadership in medical innovation and academic research.

Profile: ORCID

Featured Publications

Zhang, Y., Qiu, X., Wu, Z., Li, Y., Shen, X., Wu, J., Cao, P., Sun, Z., & Wang, W. (2025). Comprehensive analysis of the association between volatile organic compound pollutants and chronic kidney disease in hypertensive populations: Insights from multi-omics approaches and identification of potential therapeutic targets. Environmental Research, 121966.

Wu, Z., Li, S., Li, Y., Wang, Z., & Wang, W. (2025). Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity. Discover Oncology, 16, 98.

Wu, Z. (2025). Higher sexual frequency correlated with lowered PSA complex levels in U.S. men over 40 and without prostate conditions: A nationwide cross-sectional study. The Journal of Sexual Medicine.

Yan Bai | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Yan Bai | Medicine and Health Sciences | Best Researcher Award

Yunnan University | China

Dr. Yan Bai is a highly accomplished postdoctoral researcher at the State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan and the Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, China. She earned her PhD in Cell Biology from Yunnan University, MSc in Pharmacology from the Chinese PLA Medical Academy, and BSc in Pharmacy from Dali University, establishing a strong interdisciplinary foundation spanning pharmacology, microbiology, and cellular biology. Prior to her current role, she conducted research at the Chinese PLA General Hospital, focusing on combination therapies against multidrug-resistant bacteria. Her research primarily investigates mitochondrial homeostasis, tumor biology, and the molecular mechanisms underlying mitochondrial genetic diseases, with particular attention to mitochondria-associated condensates (MATOs) as regulators of protein translation and mitochondrial integrity. Dr. Yan Bai has led and contributed to several major research projects, including grants from the National Natural Science Foundation of China, the National Basic Research Program, and Yunnan Province Science and Technology initiatives. Her work has resulted in high-impact publications in journals such as Nature Aging (2025), Sci China Life Sci (2025), EMBO J (2024), and Biophys Rep (2024). According to Scopus, she has authored 10 publications, cited 177 times across 169 documents, with an h-index of 6, demonstrating both productivity and influence in her field. Through her interdisciplinary collaborations, innovative experimental approaches, and groundbreaking findings on mitochondrial regulation and aging, Dr. Yan Bai has made significant contributions to biomedical science, advancing understanding of mitochondrial biology, disease mechanisms, and translational biomedical applications.

Profile: Scopus

Featured Publications

Bai, Y., Ma, T., Zhao, S., Li, S., Wang, X., Li, J., Sun, W., Yang, Y., Liu, F., Shan, Q., Qin, Z., Liu, N., Zhang, J., Tian, F., Duan, M., Chen, S., Lai, F., Chen, Q., Wu, X., & Yang, C. (2025). Mitochondria-associated condensates maintain mitochondrial homeostasis and promote lifespan. Nature Aging.

Hao, Q., Bai, Y., Guan, R., Dong, R., Bai, W., Hamdy, H., Wang, L., Meng, M., Sun, Y., Shen, J., & Sun, J. (2025). VPS35/Retromer-dependent MT1-MMP regulation confers melanoma metastasis. Science China Life Sciences, 68(7), 1996–2009.

Hao, Q., Dong, R., Bai, W., Chang, D., Yao, X., Zhang, Y., Xu, H., Li, H., Kui, X., Wang, F., Wang, Y., Wang, C., Lei, Y., Chen, Y., Shen, J., Sang, L., Bai, Y., & Sun, J. (2024). Screening for metastasis-related genes in mouse melanoma cells through sequential tail vein injection. Biophysical Reports, 10(1), 15–21.

Liu, F., Li, T., Gong, H., Tian, F., Bai, Y., Wang, H., Yang, C., Li, Y., Guo, F., Liu, S., & Chen, Q. (2024). Structural insights into the molecular effects of the anthelmintics monepantel and betaine on the Caenorhabditis elegans acetylcholine receptor ACR-23. EMBO Journal, 43(17), 3787–3806.

Wang, T., Zhou, X., Bai, Y., Zhang, L., Li, L., & Wu, C. (2018). Antiepileptic effect of uridine may be caused by regulating dopamine release and receptor expression in corpus striatum. Brain Research, 1688, 47–53.

Bai, Y., Liu, B., Wang, T., Cai, Y., Liang, B., Wang, R., Liu, Y., & Wang, J. (2015). In vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 59(3), 1466–1471.

Liu, B., Bai, Y., Liu, Y., Di, X., Zhang, X., Wang, R., & Wang, J. (2015). In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii. Journal of Chemotherapy, 27(5), 271–276.

Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

University Hospital Basel | Switzerland

Dr. Andrej Sirek is a dedicated Pathology Resident at the University Hospital Basel, Institute of Medical Genetics and Pathology, where he is actively shaping his career at the intersection of clinical diagnostics and medical research. With his educational foundation built in leading European institutions, Dr. Andrej Sirek has developed a strong grounding in medical genetics, histopathology, and laboratory sciences, which now supports his dual role as both clinician and researcher. His residency provides him with exposure to complex pathology cases while also allowing him to engage in research that seeks to bridge genetic profiling and diagnostic pathology, with the long-term aim of contributing to precision medicine and early disease detection. Currently, he has completed one research project and is progressing with another, both expected to yield indexed publications in the near future. Despite being at an early stage of his academic career, his commitment to innovation in pathology has already been recognized with a nomination for the Best Researcher Award. He maintains active membership in several professional organizations, including SGPATH, ÖGPATH, SGZ, and ESP, which strengthens his global collaborations and engagement with the wider pathology community. While he has yet to publish peer-reviewed articles, his ongoing research demonstrates his potential to make impactful contributions to the field. His academic and professional journey underscores the promise of a new generation of clinician-scientists who integrate advanced diagnostic techniques with research innovation to improve patient care. Dr. Andrej Sirek’s trajectory highlights his dedication, scholarly potential, and commitment to excellence in pathology and medical genetics.

Profile: ORCID

Featured Publications

Dr. Andrej Sirek has contributed to impactful research in pathology, focusing on diagnostic innovations, tumor biology, and clinicopathological correlations. Key recent publications include:

Sirek, A., Hench, I. B., Hench, J., Alborelli, I., Gross, M. W., Jakscha, J., Schaller, P., Nagel, G., Baumhoer, D., & Tzankov, A. (2025). Recurrent clonal radiotherapy-associated fibroepithelial polyp of the pharynx: Do low grade radiogenic stromal tumours exist? Case report.

Sobottka, B., Vetter, V., Banaei-Esfahani, A., Nowak, M., Lorch, A., Sirek, A., Mertz, K. D., Brunelli, M., Berthold, D., de Leval, L., et al. (2024). Immune phenotype-genotype associations in primary clear cell renal cell carcinoma and matched metastatic tissue.

Nitika Dhingra | Health Professions | Best Researcher Award

Published on by Forensic Scientist

Dr. Nitika Dhingra | Health Professions | Best Researcher Award

Chitkara University | India

Dr. Nitika Dhingra  is an academic and researcher at Chitkara University, Punjab, India, with expertise in machine learning–integrated sensor development, non-destructive spectroscopy, and RF-based sensing technologies. She holds a Ph.D. in Electronics and Communication Engineering from Chitkara University, supported by an M.Tech from Punjabi University and a B.Tech from Punjab Technical University. Her research advances applications in food adulteration detection, construction material classification, and structural health monitoring of heritage sites. She has contributed significantly as a Junior and Senior Research Fellow under a DST-SHRI scheme, focusing on sensor design, embedded systems, and machine learning integration. In 2024, she secured a DST-funded research grant worth 27 Lakhs as Principal Investigator, demonstrating her leadership in high-impact projects. Her scholarly contributions include 12 publications indexed in Scopus, 9 citations across 8 documents, and an h-index of 2, along with several granted and filed patents. She has been honored with the Gandhian Young Technological Innovation Award, DST Senior Research Fellowship, and the Best Paper Presentation Award at ICAMSE, and was a semi-finalist in the DST–Texas Instruments Innovation Challenge. Dr. Nitika Dhingra’s career exemplifies innovation, academic excellence, and impactful contributions to science and technology.

Profile: Scopus

Featured Publications

  • Dhingra, N., Saluja, N., Garg, R., & Kanwar, V. (2023). Radio frequency as a non-destructive approach to concrete structure health monitoring. Iranian Journal of Science and Technology, Transactions of Civil Engineering. Cited by: 3.

  • Dhingra, N., Ghosh, D., Saluja, N., & Sabapathay, T. (2023). Radio frequency based sensor for adulteration measurement in a continuous two phase-flow of alcoholic beverages. Sensing and Imaging, 24(1), 32. Cited by: 2.

  • Dhingra, N., Saluja, N., Kanwar, V., & Garg, R. (2021). Moisture sensitive electrical property measurement in concrete slab with step graded antenna. Materials Today: Proceedings, 45, 5172–5176. Cited by: 2.

  • Dhingra, N., & Saluja, N. (2024). RF sensor-based adulterant discriminant estimation in mustard oil. Sensing and Imaging, 25(1), 59. Cited by: 1.

  • Dhingra, N., & Saluja, N. (2024). A novel non-destructive technique-based automated classification of construction material using machine learning. Asian Journal of Civil Engineering, 25(1), 805–810. Cited by: 1.

  • Geetanjali, Jindal, P., Saluja, N., Kashyap, N., & Dhingra, N. (2023). Design and optimization of wideband RF energy harvesting antenna for low-power wireless sensor applications. Proceedings of International Conference on Data Science and Applications. Cited by: 1.

Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

Published on by Forensic Scientist

Mr. Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

University of the Mountains | Cameroon

Mr. Romaric Tuono De Manfouo is an accomplished biomedical researcher specializing in hematology, infectious diseases, and public health. His work integrates laboratory investigations, epidemiological studies, and translational research to address pressing health challenges in sub-Saharan Africa. With a proven record of impactful scientific contributions, he has been involved in multidisciplinary projects exploring blood disorders, viral infections, and immunological responses. His ability to conduct rigorous clinical studies and collaborate with diverse research teams has positioned him as a respected figure in his field, committed to improving patient care through scientific advancement.

Professional Profile

Scopus

ORCID

Education

Mr. Romaric’s academic journey reflects a strong foundation in health sciences, with a focus on biomedical and clinical research. His studies provided comprehensive training in hematology, immunology, molecular biology, and epidemiology, allowing him to develop the expertise necessary to investigate complex medical conditions. Through extensive research training and practical exposure, he has acquired the skills to design and execute studies that address both laboratory-based and population-level health concerns.

Experience

Throughout his career, Mr. Romaric has worked in academic institutions, research laboratories, and collaborative health projects, contributing to knowledge generation and clinical decision-making. He has been a lead investigator and co-author on studies examining hematological profiles, hemostasis, infectious disease prevalence, and genetic conditions affecting blood health. His experience spans from advanced diagnostic testing to community-based data collection, making his work relevant to both clinical medicine and public health policy.

Research Interest

His research interests center on understanding the mechanisms and epidemiology of blood-related disorders such as sickle cell disease, glucose-6-phosphate dehydrogenase deficiency, and alloimmunization in chronic illness. He is equally engaged in studying infectious diseases including viral hepatitis and their impact on vulnerable populations such as pregnant women, newborns, and high-risk adult groups. His goal is to generate evidence that informs targeted interventions, improves early detection, and enhances patient outcomes in low-resource settings.

Awards

Mr. Romaric’s scientific achievements have been recognized through his publication record, invitations to review for international peer-reviewed journals, and collaborations with multidisciplinary research teams. His expertise is sought after in both academic and clinical research contexts, and his work continues to contribute to advancements in hematology, epidemiology, and public health.

Publications

  • Title: Abnormalities of Hemostasis in Sickle Cell Patients and Predisposition to Thrombotic Risk: A Systematic Review and Meta-Analysis
    Journal: Preprint
    Published on: 2025

  • Title: Inflammation and Iron Profile in Children With Sickle Cell Disease in Cameroon: Frequency and Associated Factors, an Analytical Cross‐Sectional Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case–Control Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Cytopenias and Associated Factors in Patients Living With HIV on ARV Treatment in Cameroon: An Analytical Cross‐Sectional Study
    Journal: Advances in Hematology
    Published on: 2025

  • Title: Haptoglobin Gene Polymorphism and Iron Profile in Sickle Cell Disease Patients With Inflammation in Yaounde, Cameroon
    Journal: Molecular Genetics & Genomic Medicine
    Published on: 2024

  • Title: Hematological And Hemostasis Profile, Thrombotic Risk In Sickle Cell Patient In Cameroon: An Analytical Cross-Sectional Study
    Journal: Hematology and Disorders
    Published on: 2024

  • Title: Hyperuricemia and Associated Factors: The Case of Outpatients at the Bafoussam Regional Hospital-Cameroon, an Analytical Cross-Sectional Study
    Journal: Health Science Reports
    Published on: 2024

Conclusion

Mr. Romaric Tuono De Manfouo exemplifies excellence in biomedical research, combining academic rigor, clinical insight, and a commitment to public health. His body of work reflects a consistent focus on improving the understanding, diagnosis, and management of hematological and infectious diseases in African populations. Through his scholarly publications, peer-review contributions, and research leadership, he continues to make significant contributions that enhance scientific knowledge and healthcare delivery. His achievements make him a worthy nominee for the Best Researcher Award, representing dedication, innovation, and scientific integrity.

Ji Li | Medicine and Health Sciences | Best Scholar Award

Published on by Forensic Scientist

Prof. Ji Li | Medicine and Health Sciences | Best Scholar Award

Central South University | China

Professor Ji Li, PhD, is a distinguished scholar in dermatological sciences, currently serving in the Department of Dermatology at Xiangya Hospital, Central South University, China. Renowned for groundbreaking research in inflammatory dermatosis and skin aging, Professor Ji has significantly advanced clinical and molecular dermatology through over a decade of academic contributions.

Author Profile👤

Scopus

Strengths for the Awards✨

Professor Ji Li, PhD, has firmly established herself as a leading figure in dermatological research, particularly in the areas of inflammatory dermatosis and skin aging. Her academic contributions are highly impactful, with over 100 SCI-indexed publications in prestigious international journals, such as BMJ, Science Advances, Developmental Cell, EMBO Journal, JAAD, JAMA Dermatology, and Journal of Investigative Dermatology. This extensive publication record underscores her sustained productivity and global recognition.

In addition to scholarly output, her ability to attract six projects funded by the National Natural Science Foundation of China (NSFC) demonstrates her competence in leading significant, peer-reviewed scientific research with national and institutional importance. Her dual roles as first and corresponding author reflect intellectual leadership and mentorship capability, making her a strong candidate for the Best Scholar Award.

🎓 Education

Professor Ji Li earned a Ph.D. in Dermatology and has since cultivated a strong academic foundation that supports both clinical excellence and scientific innovation. Their academic journey is rooted in top-tier institutions, combining rigorous research training with a focus on translational skin biology.

🧪 Experience

With a long-standing tenure at Xiangya Hospital, Professor Ji Li has blended clinical dermatology practice with laboratory-based investigation, leading several research groups and mentoring young scientists. With active involvement in national and international dermatological communities, Ji Li is recognized as a clinical-scientific leader in the field.

🔬 Research Interest On Medicine and Health Sciences

Professor Ji’s core research areas include:

  • Inflammatory dermatoses, exploring molecular mechanisms and treatment strategies

  • Skin aging, investigating cellular aging pathways and potential rejuvenation therapies
    These interests are supported by a rich body of work that bridges clinical needs and molecular science.

🏆 Award

Professor Ji Li has been honored with several prestigious recognitions, including grants from the National Natural Science Foundation of China (with 6 funded projects), underlining the scientific community’s acknowledgment of Ji’s excellence and innovation. The consistent impact of Ji’s work positions them as a leading nominee for the Best Scholar Award.

📚 Publications

Professor Ji Li has authored over 100 SCI-indexed papers as first or corresponding author, published in top-tier international journals. Notable recent publications include:

💡 Conclusion

Professor Ji Li exemplifies the values of the Best Scholar Award through a rare combination of clinical expertise, scientific vision, and impactful scholarship. With extensive contributions to inflammatory skin diseases and aging, an outstanding publication record, and robust grant support, Ji stands out as a trailblazer in dermatology research. Their leadership continues to inspire innovation, mentorship, and global collaboration.